SEGMENT ONE: 8:30am – 9:45am
The Medicare coverage conundrum: how coverage policies (or the lack thereof!) impact beneficiary access
Speakers: The Nimitt Team
This segment will begin with the aspects of Medicare that are foundational to understand – statutory definitions, beneficiary eligibility, Parts of Medicare, and hospital requirements – and then shift into discussion of the current coverage policies and processes for cell and gene therapies. The session will review the CAR-T and Stem Cell Transplant National Coverage Determinations (NCDs) as examples of national policies.
SEGMENT TWO: 10:00am – 11:30am
Cracking the code on payment: coding, charging and billing for cell and gene therapies
Speakers: The Nimitt Team
Medicare reimburses providers based on a relatively simple premise – the charges and codes providers submit on a claim. But that simple structure has layers of complexity and requirements behind it that can result in dramatic variance in payment per case. This session will use case studies with cell and gene therapies to demonstrate the “why” and “how” of the most important numbers on a claim. Key topics include: CPT and ICD-10 procedure codes, HCPCS product codes, hospital chargemasters, NUBC & HIPAA billing and claims requirements.
LUNCH 11:30am – 12:30pm
SEGMENT THREE: 12:30pm – 1:30pm
DRG, NTAP and other riddles: Medicare Inpatient Prospective Payment System (IPPS)
Speakers: The Nimitt Team
Providers are reimbursed through IPPS for any inpatient hospital care of beneficiaries. This segment will focus on the main tenants of the IPPS, including Diagnosis Related Groups (DRGs), New Technology Add-on Payment (NTAP), hospital-specific adjustors and outlier payments. The session will leverage real-world scenarios and core IPPS calculations to illustrate exactly how payments may be computed.
SEGMENT FOUR: 1:45pm – 3:30pm
Unlocking payment in the hospital outpatient and physician office settings: Medicare Physician Fee Schedule (MPFS) and Outpatient Prospective Payment System (OPPS)
Speakers: The Nimitt Team
This session will include specific topics of interest from both OPPS and MPFS for cell and gene therapies. The OPPS section will include payment for drugs, Pass-Through payment status, status indicators and ambulatory payment classifications (APCs), while the MPFS section will focus on how physicians and their teams are paid for clinical services and product administration in different places of service.
WRAP-UP: 3:00pm – 3:30pm
Putting the puzzle together: Navigating Medicare to improve access
Speakers: The Nimitt Team
We will conclude the day by bringing together key concepts from the prior sessions and answering any remaining questions from participants.